OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!
If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.
Requested Article:
A real-world analysis of FDA Adverse Event Reporting System (FAERS) events for liposomal and conventional doxorubicins
Huiling Su, Jing Jia, Yuxiang Mao, et al.
Scientific Reports (2024) Vol. 14, Iss. 1
Open Access | Times Cited: 5
Huiling Su, Jing Jia, Yuxiang Mao, et al.
Scientific Reports (2024) Vol. 14, Iss. 1
Open Access | Times Cited: 5
Showing 5 citing articles:
From Bench to Bedside: Advancing Liposomal Doxorubicin for Targeted Cancer Therapy
Mohammad Zaki Ahmad, Gulam Mustafa, Basel A. Abdel‐Wahab, et al.
Results in Surfaces and Interfaces (2025), pp. 100473-100473
Open Access
Mohammad Zaki Ahmad, Gulam Mustafa, Basel A. Abdel‐Wahab, et al.
Results in Surfaces and Interfaces (2025), pp. 100473-100473
Open Access
Breaking barriers: The potential of nanosystems in antituberculosis therapy
Christian S. Carnero Canales, Jessica Ingrid Marquez Cazorla, Renzo Marianito Marquez Cazorla, et al.
Bioactive Materials (2024) Vol. 39, pp. 106-134
Open Access | Times Cited: 3
Christian S. Carnero Canales, Jessica Ingrid Marquez Cazorla, Renzo Marianito Marquez Cazorla, et al.
Bioactive Materials (2024) Vol. 39, pp. 106-134
Open Access | Times Cited: 3
Alternative Strategies for Delivering Immunotherapeutics Targeting the PD-1/PD-L1 Immune Checkpoint in Cancer
Ryunosuke Hoshi, Kristyna A. Gorospe, Hagar I. Labouta, et al.
Pharmaceutics (2024) Vol. 16, Iss. 9, pp. 1181-1181
Open Access | Times Cited: 2
Ryunosuke Hoshi, Kristyna A. Gorospe, Hagar I. Labouta, et al.
Pharmaceutics (2024) Vol. 16, Iss. 9, pp. 1181-1181
Open Access | Times Cited: 2
In vitro assessment of nanomedicines' propensity to cause palmar-plantar erythrodysesthesia: A Doxil vs. doxorubicin case study
Edward Cedrone, Abbas Ishaq, Emma Grabarnik, et al.
Nanomedicine Nanotechnology Biology and Medicine (2024) Vol. 62, pp. 102780-102780
Closed Access
Edward Cedrone, Abbas Ishaq, Emma Grabarnik, et al.
Nanomedicine Nanotechnology Biology and Medicine (2024) Vol. 62, pp. 102780-102780
Closed Access
Enhancing Gentamicin Antibacterial Activity by Co-Encapsulation with Thymoquinone in Liposomal Formulation
Raghad Alzahrani, Manal M. Alkhulaifi, Majed Al-Jeraisy, et al.
Pharmaceutics (2024) Vol. 16, Iss. 10, pp. 1330-1330
Open Access
Raghad Alzahrani, Manal M. Alkhulaifi, Majed Al-Jeraisy, et al.
Pharmaceutics (2024) Vol. 16, Iss. 10, pp. 1330-1330
Open Access
